Evidence map›Paper›PMID 33488120›Full record

ArticleCancer management and research2021

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.

Xin-Ping Yu, Lei Wang, Hai-Yang Yu, Yu-Wei Zou, Chang Wang, Jin-Wen Jiao, Hao Hong, Shuai Zhang

Abstract read
In one paragraph

Article in Cancer management and research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin-Ping YuDepartment of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.
Lei WangDepartment of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.
Hai-Yang YuDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.
Yu-Wei ZouDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.
Chang WangDepartment of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.
Jin-Wen JiaoDepartment of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.
Hao HongDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, People's Republic of China.ORCID 0000-0003-1653-4026
Shuai ZhangDepartment of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People's Republic of China.ORCID 0000-0002-3580-6034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether multidetector computed tomography (MDCT)-based radiomics features can discriminate between serous borderline ovarian tumors (SBOTs) and serous malignant ovarian tumors (SMOTs). PATIENTS AND

methodsEighty patients with SBOTs and 102 patients with SMOTs, confirmed by pathology (training set: n = 127; validation set: n = 55) from December 2017 to June 2020, were enrolled in this study. The interclass correlation coefficient (ICC) and least absolute shrinkage and selection operator (LASSO) regression were applied to select radiomics parameters derived from MDCT images on the arterial phase (AP), venous phase (VP), and equilibrium phase (EP). Receiver operating characteristic (ROC) analysis of each selected parameter was carried out. Heat maps were created to illustrate the distribution of the radiomics parameters. Three models incorporating selected radiomics parameters generated by support vector machine (SVM) classifiers in each phase were analyzed by ROC and compared using the DeLong test.

resultsThe most predictive features selected by ICC and LASSO regression between SBOTs and SMOTs included 9 radiomics parameters on AP, VP, and EP each. Three models on AP, VP, and EP incorporating the selected features generated by SVM classifiers produced AUCs of 0.80 (accuracy, 0.75; sensitivity, 0.74; specificity, 0.75), 0.86 (accuracy, 0.78; sensitivity, 0.80; specificity, 0.75), and 0.73 (accuracy, 0.69; sensitivity, 0.71; specificity, 0.67), respectively. There were no significant differences in the AUCs among the three models (AP vs. VP, P = 0.199; AP vs. EP, P = 0.260; VP vs. EP, P = 0.793).

conclusionMDCT-based radiomics features could be used as biomarkers for the differentiation of SBOTs and SMOTs.

Indexed as

multidetector computed tomography; MDCTovarian tumorsradiomics

Identifiers

PMID33488120
PMCPMC7814232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.